XML 55 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Compensation (Table)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Company's Equity Plans

The table below summarizes the Company's equity plans as of December 31, 2024:

 

Plan

 

Maximum Number of Shares Authorized

 

 

Shares Available for Future Issuance

 

2024 Inducement Plan

 

 

1,250,000

 

 

 

71,075

 

2021 Equity Incentive Plan

 

 

6,873,404

 

 

 

682,278

 

2017 Equity Incentive Plan

 

 

2,275,305

 

 

 

 

2021 Employee Stock Purchase Plan

 

 

1,148,444

 

 

 

1,059,692

 

Summary of Share-based Compensation Arrangements by Share-based Payment Award

Stock option activity under the 2017 EIP, 2021 EIP, and 2024 Inducement Plan is summarized as follows:

 

 

Number of Options

 

 

Weighted-Average Exercise Price per Share

 

 

Weighted-Average Remaining Contractual Life (Years)

 

 

Aggregate Intrinsic Value (000s)

 

Outstanding as of December 31, 2023

 

 

5,762,236

 

 

$

9.42

 

 

 

7.66

 

 

$

39,197

 

Granted

 

 

2,799,750

 

 

$

25.83

 

 

 

 

 

 

 

Exercised

 

 

(1,486,314

)

 

$

8.66

 

 

 

 

 

 

 

Cancelled and forfeited

 

 

(463,875

)

 

$

10.93

 

 

 

 

 

 

 

Outstanding as of December 31, 2024

 

 

6,611,797

 

 

$

16.44

 

 

 

8.11

 

 

$

172,630

 

Options exercisable as of December 31, 2024

 

 

2,703,670

 

 

$

9.65

 

 

 

7.11

 

 

$

88,257

 

Vested and expected to vest as of December 31, 2024

 

 

6,611,797

 

 

$

16.44

 

 

 

8.11

 

 

$

172,630

 

Summary of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity The following table shows RSU activity for the period ending December 31, 2024:

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value per Share

 

Unvested balance at December 31, 2023

 

 

131,679

 

 

$

18.36

 

Granted

 

 

713,812

 

 

 

29.67

 

Vested

 

 

(111,396

)

 

 

19.03

 

Cancelled and forfeited

 

 

(37,207

)

 

 

22.33

 

Unvested balance at December 31, 2024

 

 

696,888

 

 

$

29.63

 

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

The following tables summarize the stock-based compensation expense for stock options and restricted stock units granted to employees and nonemployees and for ESPP stock-based compensation that was recorded in the Company’s statements of operations and comprehensive loss for the years ended December 31, 2024 and 2023 (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Research and development

 

$

8,537

 

 

$

4,845

 

General and administrative

 

 

12,265

 

 

 

6,648

 

Total stock-based compensation expense

 

$

20,802

 

 

$

11,493

 

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Employees

 

$

18,356

 

 

$

10,494

 

Nonemployees

 

 

2,446

 

 

 

999

 

Total stock-based compensation expense

 

$

20,802

 

 

$

11,493

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of stock options granted during the years ended December 31, 2024 and 2023, was estimated using the Black-Scholes option pricing model based on the following assumptions:

 

 

Year Ended December 31,

 

2024

 

2023

Expected term (in years)

 

5.4 – 6.1

 

5.5 – 6.1

Expected volatility

 

69.7% – 73.2%

 

79.5% – 80.5%

Risk-free rate

 

3.6% – 4.6%

 

3.4% – 4.7%

Dividend yield